|
|
||||||||||
Internal Medicine Resident, Akron General Medical Center, Akron, OH
Pharmacotherapy Specialist, Internal Medicine, Akron General Medical Center; Associate Professor of Clinical Pharmacology in Internal Medicine, Northeastern Ohio Universities College of Medicine, Akron
Chair, Department of Internal Medicine, Akron General Medical Center; Professor of Medicine, Northeastern Ohio Universities College of Medicine
Reprints: Lawrence A Frazee PharmD, Akron General Medical Center, 400 Wabash Ave., Akron, OH 44307-2463, fax 330/996-2395, lfrazee{at}agmc.org
OBJECTIVE: To review the literature regarding the management of asymptomatic bacteriuria (ASB) in patients with diabetes mellitus.
DATA SOURCES: A MEDLINE (1967-June 2003) and bibliographic search of the English-language literature was conducted using the search terms diabetes mellitus, asymptomatic, bacteriuria, and urinary tract infection.
DATA SYNTHESIS: ASB occurs in diabetic women more commonly than in non-diabetics and is associated with an increased risk of symptomatic urinary tract infection (UTI) among patients with type 2 diabetes. Symptomatic UTIs tend to follow a more complicated course in diabetics. Despite these independent observations, antimicrobial therapy has not been shown to reduce symptomatic UTIs, pyelonephritis, or hospitalization for UTI.
CONCLUSIONS: Available evidence does not support antimicrobial treatment of ASB among patients with diabetes mellitus.
Key Words: bacteriuria, diabetes mellitus
Published Online, January 23, 2004. www.theannals.com, DOI 10.1345/aph.1D355
This article has been cited by other articles:
![]() |
A. Nareika, Y.-B. Im, B. A Game, E. H Slate, J. J Sanders, S. D London, M. F Lopes-Virella, and Y. Huang High glucose enhances lipopolysaccharide-stimulated CD14 expression in U937 mononuclear cells by increasing nuclear factor {kappa}B and AP-1 activities J. Endocrinol., January 1, 2008; 196(1): 45 - 55. [Abstract] [Full Text] [PDF] |
||||